KROS
Keros Therapeutics, Inc.Closed11.23−0.38 −3.27%USD
NasdaqGM · as of Oct 13, 16:00 ET · 15m delayAfter hours 11.30 +0.62%
Open
11.69
Prev close
11.61
Day range
11.1911.69
52-week range
9.6922.55
Volume
143.61K0.75×
Mkt cap
222.66M
P/E ttm
—
Fwd P/E
-1.70
EPS ttm
-3.22
Div yield
0.00%
Earnings
Aug 3, 2026
From 52w high
−50.20%
KROS earnings and estimates
KROS Next Report
Yahoo Finance · Nasdaq
Report date
Wed, Nov 4
After the close · estimated
EPS consensus
$−0.86
range −1.53 – −0.56
EPS growth vs year ago
−377.8%
year ago −0.18
Revenue consensus
$13.89M
−2.6% vs year ago
Options-implied move
—
no expiry soon after the report
Past 4 reactions
±7.0%
average move · beat 1 of 4
EPS: Actual vs Estimate
Price Reaction
close before → close after the report
Recent Reports
| Quarter ending | Reported | EPS | Estimate | Surprise | Revenue | Next session | Five sessions |
|---|---|---|---|---|---|---|---|
| Jun '26 | Aug 3, 2026 AMC | −1.45 | −1.24 | −16.75% | $0 | +1.4% | +5.7% |
| Mar '26 | May 14, 2026 BMO | −1.21 | −0.92 | −31.52% | $367.00K | −8.3% | −8.4% |
| Dec '25 | Mar 4, 2026 AMC | −0.86 | −0.45 | −90.40% | $385.00K | −15.0% | −18.2% |
| Sep '25 | Nov 5, 2025 AMC | −0.18 | −0.92 | +80.46% | $14.26M | +3.3% | +11.6% |
Consensus Estimates and Revisions
| Period | EPS | Low · range · high | Growth | Revenue | Growth | 30d ago | 90d ago | Up / down (30d) |
|---|---|---|---|---|---|---|---|---|
| Current quarter Sep 2026 | −0.86 | −1.53−0.56 | −377.8% | $13.89M | −2.6% | −1.30 +33.7% | −1.34 +36.1% | 3 / 1 |
| Next quarter Dec 2026 | −1.78 | −1.97−1.49 | −107.0% | $478.57K | +24.3% | −1.44 −23.6% | −1.43 −24.7% | 0 / 5 |
| Current year Dec 2026 | −5.22 | −5.90−4.62 | −327.0% | $15.57M | −93.6% | −5.19 −0.7% | −5.23 +0.1% | 3 / 2 |
| Next year Dec 2027 | −6.62 | −8.93−3.84 | −26.7% | $13.73M | −11.8% | −5.59 −18.3% | −6.22 −6.3% | 0 / 6 |
The change columns show how the consensus has moved since then; steady upward revisions often precede beats. Ranges place the consensus between the lowest and highest analyst estimate.
Forward EPS Forecasts
Nasdaq · Zacks consensus
Quarterly
| Fiscal period | Consensus | Low · range · high | Analysts | Up / down (4w) |
|---|---|---|---|---|
| Sep 2026 | −0.96 | −1.53−0.65 | 3 | 0 / 0 |
| Dec 2026 | −1.72 | −1.97−1.49 | 3 | 0 / 0 |
| Mar 2027 | −2.10 | — | 1 | 0 / 0 |
| Jun 2027 | −2.21 | — | 1 | 0 / 0 |
| Sep 2027 | −2.30 | — | 1 | 0 / 0 |
Fiscal years
| Fiscal period | Consensus | Low · range · high | Analysts | Up / down (4w) |
|---|---|---|---|---|
| Dec 2026 | −5.27 | −5.90−4.62 | 4 | 0 / 0 |
| Dec 2027 | −6.39 | −8.93−3.84 | 5 | 0 / 0 |
| Dec 2028 | −6.05 | −9.12−3.31 | 3 | 0 / 0 |
| Dec 2029 | −6.06 | −11.65−3.14 | 3 | 0 / 0 |
Reactions run from the last close before a report to the first close after it (an after-the-close report is measured to the next day's close). The implied move is the at-the-money straddle for the first expiry after the report, the same rule as the bot's lgf emove.